CONNEQT Health Limited (ASX:CQT)
Australia · Delayed Price · Currency is AUD 0.0359
+0.0019 (5.59%)
At close: Oct 30, 2025
CONNEQT Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Operating Revenue | 3.55 | 10.91 | 4.6 | 4.07 | 4.98 | Upgrade |
Other Revenue | 2.5 | 1.91 | 1.09 | 0.67 | 0.53 | Upgrade |
| 6.05 | 12.81 | 5.69 | 4.74 | 5.52 | Upgrade | |
Revenue Growth (YoY) | -52.76% | 125.14% | 20.12% | -14.11% | 15.45% | Upgrade |
Cost of Revenue | 1.82 | 0.8 | 0.91 | 1.01 | 0.9 | Upgrade |
Gross Profit | 4.23 | 12.02 | 4.79 | 3.73 | 4.61 | Upgrade |
Selling, General & Admin | 13.81 | 14 | 14.17 | 11.38 | 5.98 | Upgrade |
Research & Development | 2.21 | 2.49 | 3.91 | 2.38 | 1.75 | Upgrade |
Amortization of Goodwill & Intangibles | 0.1 | 0.01 | - | - | - | Upgrade |
Other Operating Expenses | - | - | - | - | 0.35 | Upgrade |
Operating Expenses | 17.03 | 16.65 | 20.14 | 15.77 | 9.48 | Upgrade |
Operating Income | -12.8 | -4.63 | -15.35 | -12.04 | -4.86 | Upgrade |
Interest Expense | -0.66 | -1.18 | -0.41 | -0.23 | -0.27 | Upgrade |
Interest & Investment Income | 0 | 0.27 | 0.26 | 0.43 | 0.26 | Upgrade |
Currency Exchange Gain (Loss) | 0.05 | 0.01 | 0.07 | 0.3 | -0.53 | Upgrade |
Other Non Operating Income (Expenses) | - | -0.44 | -3.45 | -0.28 | 0.01 | Upgrade |
EBT Excluding Unusual Items | -13.41 | -5.98 | -18.89 | -11.81 | -5.4 | Upgrade |
Gain (Loss) on Sale of Investments | -4.79 | -0.79 | - | - | -0.06 | Upgrade |
Other Unusual Items | - | - | - | - | 0.29 | Upgrade |
Pretax Income | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 | Upgrade |
Net Income | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 | Upgrade |
Net Income to Common | -18.19 | -6.77 | -18.89 | -11.81 | -5.16 | Upgrade |
Shares Outstanding (Basic) | 354 | 201 | 130 | 103 | 87 | Upgrade |
Shares Outstanding (Diluted) | 354 | 201 | 130 | 103 | 87 | Upgrade |
Shares Change (YoY) | 76.59% | 54.14% | 26.31% | 18.02% | 20.09% | Upgrade |
EPS (Basic) | -0.05 | -0.03 | -0.15 | -0.11 | -0.06 | Upgrade |
EPS (Diluted) | -0.05 | -0.03 | -0.15 | -0.12 | -0.06 | Upgrade |
Free Cash Flow | -10.92 | -7.84 | -12.05 | -9.57 | -4.04 | Upgrade |
Free Cash Flow Per Share | -0.03 | -0.04 | -0.09 | -0.09 | -0.05 | Upgrade |
Gross Margin | 69.92% | 93.77% | 84.08% | 78.75% | 83.66% | Upgrade |
Operating Margin | -211.42% | -36.16% | -269.73% | -254.02% | -88.13% | Upgrade |
Profit Margin | -300.58% | -52.80% | -331.86% | -249.25% | -93.54% | Upgrade |
Free Cash Flow Margin | -180.45% | -61.19% | -211.80% | -202.02% | -73.31% | Upgrade |
EBITDA | -12.64 | -4.56 | -15.28 | -11.97 | -4.71 | Upgrade |
EBITDA Margin | -208.79% | -35.59% | -268.46% | -252.71% | -85.47% | Upgrade |
D&A For EBITDA | 0.16 | 0.07 | 0.07 | 0.06 | 0.15 | Upgrade |
EBIT | -12.8 | -4.63 | -15.35 | -12.04 | -4.86 | Upgrade |
EBIT Margin | -211.42% | -36.16% | -269.73% | -254.02% | -88.13% | Upgrade |
Revenue as Reported | 6.11 | 13.09 | 6.02 | 5.47 | 6.07 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.